Virtu Financial LLC Galmed Pharmaceuticals Ltd. Transaction History

Virtu Financial LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 01, 2023	BUY	$0.4 - $0.9 $12,653 - $28,469	31,633 New	31,633 $13,000
Q3 2022 Nov 07, 2022	BUY	$0.35 - $59.37 $7,891 - $1.34 Million	22,548 New	22,548 $7,000
Q1 2022 May 17, 2022	SELL	$1.23 - $2.07 $44,246 - $74,464	-35,973 Closed	0 $0
Q4 2021 Feb 17, 2022	BUY	$1.75 - $3.03 $62,952 - $108,998	35,973 New	35,973 $65,000
Q3 2020 Dec 11, 2020	SELL	$3.46 - $5.69 $51,733 - $85,076	-14,952 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$3.22 - $6.08 $48,145 - $90,908	14,952 New	14,952 $71,000
Q2 2018 Jul 30, 2018	SELL	$5.04 - $17.96 $70,423 - $250,955	-13,973 Closed	0 $0
Q2 2018 Jul 30, 2018	BUY	$5.04 - $17.96 $70,423 - $250,955	13,973 New	13,973 $166,000

Ticker GLMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,088,400
Market Cap $178M
Description
Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or t...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.